Los medicamentos similares: ¿una nueva clase de medicina o sólo una estrategia comercial?
Loading...
Date
Authors
Domínguez Pérez, David Alfredo
Pérez Rul, María Natalia
relationships.isAuthorOf2
relationships.isAuthorOf3
relationships.isAuthorOf4
relationships.isAuthorOf6
relationships.isAuthorOf7
relationships.isAuthorOf8
relationships.isAuthorOf5
Journal Title
Journal ISSN
Volume Title
Publisher
México D. F., México : CIECAS – IPN
item.qr.title
item.qr.description
item.metrics.title
Altmetric
Dimensions
PlumX
Scopus
Abstract
Description
Existe gran confusión acerca de lo que son los medicamentos similares, la Secretaría de Salud no los define legalmente como algún tipo de medicamento; en el sector comercio se les identifica como tal. Los denominados medicamentos similares son medicinas genéricas, que hasta el día de hoy, no han efectuado las pruebas de bioequivalencia y biodisponibilidad, las Farmacias Similares les dieron esta designación, como una estrategia comercial de diferenciación de sus competidores; el éxito de esta propuesta comercial se debe a varios factores, el más importante es la accesibilidad en los precios, en comparación con otro tipo de medicamentos que se encuentran en el mercado, lo que ha hecho un modelo de negocio no sólo en México, sino en Latinoamérica.
A big confusion exists since about what they are the similar medications, the Secretary of Health it doesn’t define them legally as some medication type, but at commercial level they are identified as such, the denominated similar medications are generic medications that have not made the bioequivalence tests, the Pharmacies of Similar gave them this appointment, to be a commercial strategy of their competitors’ differentiation; the success of this commercial proposal is due to several points, but the most important is the accessibility in the prices, in comparison of the other types of medications that are in the market, what has made a model of non alone business in Mexico, but in Latin America.
A big confusion exists since about what they are the similar medications, the Secretary of Health it doesn’t define them legally as some medication type, but at commercial level they are identified as such, the denominated similar medications are generic medications that have not made the bioequivalence tests, the Pharmacies of Similar gave them this appointment, to be a commercial strategy of their competitors’ differentiation; the success of this commercial proposal is due to several points, but the most important is the accessibility in the prices, in comparison of the other types of medications that are in the market, what has made a model of non alone business in Mexico, but in Latin America.
item.page.notes
item.page.medium
item.page.tipo
Artículo
Date
2009-09
item.page.doi
item.page.isbn
item.page.ispartofseries
item.page.paginacion
p. 77-86
item.page.lugar
item.page.cita
Domínguez Pérez, David Alfredo y María Natalia Pérez Rul. 2009. Los medicamentos similares: ¿una nueva clase de medicina o sólo una estrategia comercial? (Artículos y Miscelánea). Mundo Siglo XXI. Revista del Centro de Investigaciones Económicas, Administrativas y Sociales del Instituto Politécnico Nacional, 18: 77-86.